Increased Rates of Hospitalization Linked to Elder Abuse

Increased Rates of Hospitalization Linked to Elder Abuse

Older adults who are subject to elder abuse, neglect and exploitation face a greater risk of being hospitalized than other seniors, according to the results of a study published in the April 8 issue of JAMA Internal Medicine. “Elder abuse is independently associated with increased mortality risk, especially for cardiovascular related [...]

Read more ›

Novel Inhibitor to Overcome Drug Resistance Induced by RAF, MEK Inhibitors

Novel Inhibitor to Overcome Drug Resistance Induced by RAF, MEK Inhibitors

A new class of investigational medicines may help to treat patients with cancers driven by mutations in genes such as BRAF or KRAS/NRAS, including those patients who have become resistant to therapies that target BRAF directly, according to preclinical data presented at the AACR Annual Meeting 2013, held in Washington, [...]

Read more ›

Targeted Toxin Active in Platinum-Resistant Ovarian Cancers

Targeted Toxin Active in Platinum-Resistant Ovarian Cancers

A new antibody-guided drug has shown promising activity in a phase I trial involving ovarian cancer patients with platinum drug-resistant disease, researchers from Dana-Farber Cancer Institute will report today at the annual meeting of the American Association for Cancer Research. The findings (abstract LB-290) will be discussed at a press [...]

Read more ›